Sumitomo Pharma Co., Ltd.

SMDPY · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$594$11,206$2,415$53,448
Dep. & Amort.$36$5,203$5,807$6,066
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$134-$7,848-$733$183
Other Non-Cash-$370-$8,562$3,520-$58,758
Operating Cash Flow$126-$1$11,009$939
Investing Activities
PP&E Inv.-$11-$1,474-$2,375-$2,057
Net Acquisitions$210-$2,338$539-$539
Inv. Purchases-$18$0$0$0
Inv. Sales/Matur.$23$0$0$0
Other Inv. Act.$16$3,782$4,147$2,588
Investing Cash Flow$220-$30$2,311-$8
Financing Activities
Debt Repay.-$321-$670-$28,271$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0-$1-$1-$1
Other Fin. Act.-$5$693-$35,263-$15,864
Financing Cash Flow-$325$22-$63,535-$15,865
Forex Effect$98-$4$1,110$117
Net Chg. in Cash$119-$13-$62,277$85,393
Supplemental Information
Beg. Cash$142$155$85,393$99,082
End Cash$261$142$23,116$85,393
Free Cash Flow$118-$1,666$8,634-$1,118